Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
SYK · NYSE · United States · Surgical & Medical Instruments & Apparatus
In shortSTRYKER CORP is profitable, generates cash and carries moderate debt, with revenue growing (+11.2% last year).
Financial health
Strong
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 19.5% | 82/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 12.9% | 72/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 15.1% | 75/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 9.2% | 61/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.89× | 91/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.71× | 72/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.82× | 62/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 8.05× | 62/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 3.96 | 73/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 17.1% | 88/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.32× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 4.3% | 95/100 |
| Operating margin volatility | 2.0% | 91/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 10.8% | 77/100 |
|---|---|---|
| EPS growth, 3-year average | 10.8% | 79/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 17,108 | 18,449 | 20,498 | 22,595 | 25,116 |
| Cost of revenue | 6,140 | 6,871 | 7,440 | 8,155 | 9,051 |
| Gross profit | 10,968 | 11,578 | 13,058 | 14,440 | 16,065 |
| Research & development | 1,235 | 1,454 | 1,388 | 1,466 | 1,623 |
| Selling, general & admin | 6,427 | 6,386 | 7,111 | 7,685 | 8,651 |
| Operating income | 2,584 | 2,841 | 3,888 | 3,689 | 4,889 |
| Interest expense | 337 | 337 | 363 | 409 | 607 |
| Pre-tax income | 2,281 | 2,683 | 3,673 | 3,492 | 4,514 |
| Income tax | 287 | 325 | 508 | 499 | 1,268 |
| Net income | 1,994 | 2,358 | 3,165 | 2,993 | 3,246 |
| Diluted EPS | $5.21 | $6.17 | $8.25 | $7.76 | $8.40 |
| Diluted shares (millions) | 382 | 382 | 384 | 386 | 387 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
3.96 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Jul 31, 2026